Track the 케이엠제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Banks sector, 케이엠제약 has recorded 56 reports. Market capitalisation: €9.7bn. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: 강일모. The full history is free.
50
Insider Decl.
n/a
Thresholds
€109,057
36 ops.
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
Buys €109,057n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,117 of 28,134 companies
13.5
score / 100
Value
8
Quality
19
FCF yld-20%
Earn yld-40%
EV/EBITDA·
ROE-13%
Gross mgn24%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.